Accelerated healing of diabetic wounds by NorLeu(3)-angiotensin (1-7).
Accelerated healing of diabetic wounds by NorLeu(3)-angiotensin (1-7).
复制标题
DOI:
10.1517/13543784.2011.619976
复制
发表时间:
2011-11
影响因子:
6.1
通讯作者:
Dizerega G
中科院分区:
文献类型:
--
作者:
Rodgers K;Verco S;Bolton L;Dizerega G
Diabetes is a disorder that is well known to delay wound repair resulting in the formation of colonized, chronic wounds. The resultant ulcers contribute to increased risk of morbidity, including osteomyelitis and amputations, and increased burden to the health care system. The only active product approved for the treatment of diabetic ulcers, Regranex, has been shown to reduce amputation risk, but is not widely used due to minimal proven efficacy and recent warnings added to the Instructions for Use. Here, we overview the development of NorLeu3-angiotensin (1-7) (NorLeu3-A(1-7)) as an active agent for the treatment of diabetic wounds. NorLeu3-A(1-7) is an analogue of the naturally occurring peptide, angiotensin 1-7. The mechanisms of action include induction of progenitor proliferation and accelerated vascularization, collagen deposition and re-epithelialization. Research to date has shown that NorLeu3-A(1-7) is highly effective in the closure of diabetic wounds and is superior to Regranex in animal studies. Further clinical development of this product as a topical agent for the healing of chronic wounds and investigation into the mechanisms by which this product accelerates healing are warranted.
登录
查看更多内容
影响因子:
16.2
作者:
Wieman, TJ;Smiell, JM;Su, YC
通讯作者:
Su, YC
影响因子:
2.9
作者:
Rodgers, Kathleen;Abiko, Masami;Dizerega, Gere
通讯作者:
Dizerega, Gere
影响因子:
15.9
作者:
Mrug, M;Stopka, T;Prchal, JT
通讯作者:
Prchal, JT
影响因子:
7.5
作者:
Kurosaka, Maya;Suzuki, Tatsunori;Majima, Masataka
通讯作者:
Majima, Masataka
影响因子:
3
作者:
Rodgers, K;Xiong, SQ;diZerega, GS
通讯作者:
diZerega, GS